Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://karimvryh219417.answerblogs.com/39353468/trelaglutide-exploring-a-new-option-for-chronic-diseases